Epigallocatechin-3-gallate reduces inflammation induced by calcium pyrophosphate crystals in vitro

Frontiers in Pharmacology

Volumn 4 APR, Issue , 2013, Pages

  Oliviero, Francesca ^a   Sfriso, Paolo ^a   Scanu, Anna ^a   Fiocco, Ugo ^a   Spinella, Paolo ^a   Punzi, Leonardo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Chemokines; Cytokines; Epigallocatechin 3 gallate; Inflammation; Osteoarthritis

Indexed keywords

CALCIUM PYROPHOSPHATE; EPIGALLOCATECHIN GALLATE; INTERLEUKIN 1BETA; INTERLEUKIN 8; METHYL BETA CYCLODEXTRIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STIMULATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOSE RESPONSE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIPID RAFT; MEMBRANE STRUCTURE; MONONUCLEAR CELL; NEUTROPHIL CHEMOTAXIS; OSTEOARTHRITIS; SYNOVIOCYTE;

EID: 84881526350     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2013.00051     Document Type: Article

References (30)

1. Ahmed, S., Pakozdi, A., and Koch, A. E. (2006). Regulation of interleukin-1ß-induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 54, 393-401.
2. Benito, M. J., Veale, D. J., FitzGerald, O., van den Berg, W. B., and Bresnihan, B. (2005). Synovial tissue inflammation in early and late osteoarthritis. Ann. Rheum. Dis. 64, 1263-1267.
3. Busso, N., and Ea, H. K. (2012). The mechanisms of inflammation in gout and pseudogout (CPP-induced arthritis). Reumatismo 63, 230-237.
4. Dingle, J. T. (1991). Cartilage maintenance in osteoarthritis: interaction of cytokines, NSAID and prostaglandins in articular cartilage damage and repair. J. Rheumatol. 18, 30-37.
5. Duhon, D., Bigelow, R. L., Coleman, D. T., Steffan, J. J., Yu, C., Langston, W., et al. (2010). The polyphenol epigallocatechin-3-gallate affects lipid rafts to block activation of the c-Met receptor in prostate cancer cells. Mol. Carcinog. 49, 739-749.
6. Fuerst, M., Bertrand, J., Lammers, L., Dreier, R., Echtermeyer, F., Nitschke, Y., et al. (2009). Calcification of articular cartilage in human osteoarthritis. Arthritis Rheum. 60, 2694-2703.
7. Gibilisco, P., Schumaker, H. J., Hollander, J., and Soper, K. (2009). Synovial fluid crystal in osteoarthritis. Arthritis Rheum. 28, 511-515.
8. Gombault, A., Baron, L., and Couillin, I. (2012). ATP release and purinergic signaling in NLRP3 inflammasome activation. Front. Immunol. 3:414. doi: 10.3389/fimmu.2012.00414
9. Jaovisidha, K., and Rosenthal, A. K. (2002). Calcium crystals in osteoarthritis. Curr. Opin. Rheumatol. 14, 298-302.
10. Lee, M. J., Maliakal, P., Chen, L., Meng, X., Bondoc, F. Y., Prabhu, S., et al. (2002). Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol. Biomarkers Prev. 11, 1025-1032.
11. Liu-Bryan, R., and Lioté, F. (2005). Monosodium urate and calcium pyrophosphate dihydrate crystals, inflammation, and cellular signaling. Joint Bone Spine 72, 295-302.
12. Long, L. H., and Halliwell, B. (2009). Artefacts in cell culture: pyruvate as a scavenger of hydrogen peroxide generated by ascorbate or epigallocatechin gallate in cell culture media. Biochem. Biophys. Res. Commun. 388, 700-704.
13. Lotz, M., Rosen, F., McCabe, G., Quach, J., Blanco, F., Dudler, J., et al. (1995). Interleukin 1 beta suppresses transforming growth factor-induced inorganic pyrophosphate (PPi) production and expression of the PPi-generating enzyme PC-1 in human chondrocytes. Proc. Natl. Acad. Sci. U.S.A. 92, 10364-10368.
14. Mak, J. C. (2012). Potential role of green tea catechins in various disease therapies: progress and promise. Clin. Exp. Pharmacol. Physiol. 39, 265-273.
15. Manning, J., and Roberts, J. C. (2003). Analysis of catechin content of commercial green tea products. J. Herb. Pharmacother. 3, 19-32.
16. Margina, D., Ilie, M., Manda, G., Neagoe, I., Mocanu, M., Ionescu, D., et al. (2012). Quercetin and epigallocatechin gallate effects on the cell membranes biophysical properties correlate with their antioxidant potential. Gen. Physiol. Biophys. 31, 47-55.
17. Morinobu, A., Biao, W., Tanaka, S., Horiuchi, M., Jun, L., Tsuji, G., et al. (2008). Epigallocatechin-3-gallate suppresses osteoclast differentiation and ameliorates experimental arthritis in mice. Arthritis Rheum. 58, 2012-2018.
18. Mylona, E. E., Mouktaroudi, M., Crisan, T. O., Makri, S., Pistiki A., Georgitsi, M., et al. (2012). Enhanced interleukin-1ß production of PBMCs from patients with gout after stimulation with Toll-like receptor-2 ligands and urate crystals. Arthritis Res. Ther. 14, R158.
19. Nalbant, S., Martinez, J. A., Kitumnuaypong, T., Clayburne, G., Sieck, M., and Schumacher, H. R. Jr. (2003). Synovial fluid features and their relations to osteoarthritis severity: new findings from sequential studies. Osteoarthr. Cartil. 11, 50-54.
20. Oliviero, F., Scanu, A., Dayer, J. M., Fiocco, U., Sfriso, P., and Punzi, L. (2012a). Response to 'Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4'. Arthritis Res. Ther. 14, 405.
21. Oliviero, F., Scanu, A., Galozzi, P., Gava, A., Frallonardo, P., Ramonda, R., et al. (2012b). Prevalence of calcium pyrophosphate and monosodium urate crystals in synovial fluid of patients with previously diagnosed joint diseases. Joint Bone Spine. doi: 10.1016/j.jbspin.2012.08.006 [Epub ahead of print].
22. Olmez, U., Ryan, L. M., Kurup, I. V., and Rosenthal, A. K. (1994). Insulin-like growth factor-1 suppresses pyrophosphate elaboration by transforming growth factor beta1-stimulated chondrocytes and cartilage. Osteoarthr. Cartil. 2, 149-154.
23. Punzi, L., Oliviero, F., and Plebani, M. (2005). New biochemical insights into the pathogenesis of osteoarthritis and the role of laboratory investigations in clinical assessment. Crit. Rev. Clin. Lab. Sci. 42, 279-309.
24. Punzi, L., Oliviero, F., and Ramonda, R. (2003). Transforming growth factor-beta levels in synovial fluid of osteoarthritis with or without calcium pyrophosphate dihydrate crystals. J. Rheumatol. 30, 420-421.
25. Scanu, A., Oliviero, F., Braghetto, L., Ramonda, R., Luisetto, R., Calabrese, F., et al. (2007). Synoviocyte cultures from synovial fluid. Reumatismo 59, 66-70.
26. Scanu, A., Oliviero, F., Gruaz, L., Sfriso, P., Pozzuoli, A., Frezzato, F., et al. (2010). High-density lipoproteins downregulate CCL2 production in human fibroblast-like synoviocytes stimulated by urate crystals. Arthritis Res. Ther. 12, R23.
27. Schlesinger, N., Hassett, A. L., Neustadter, L., and Schumacher, H.R. Jr. (2009). Does acute synovitis (pseudogout) occur in patients with chronic pyrophosphate arthropathy (pseudo-osteoarthritis)? Clin. Exp. Rheumatol. 27, 940-944.
28. Swan, A., Heywood, B., Chapman, B., Seward, H., and Dieppe, P. (1995). Evidence for a causal relationship between the structure, size, and load of calcium pyrophosphate dihydrate crystals, and attacks of pseudogout. Ann. Rheum. Dis. 54, 825-830.
29. Tsuchiya, H. (1999). Effects of green tea catechins on membrane fluidity. Pharmacology 59, 34-44.
30. Tsuchiya, H., Tanaka, T., and Nagayama, M. (2008). Antiproliferative effects associated with membrane lipid interaction of green tea catechins. J. Health Sci. 54, 576-580.